Sophia Genetics CFO Ross Muken promoted to president, George Cardoza to succeed

Sophia Genetics (SOPH) announced that Ross Muken, previously CFO and COO, has been promoted to company president, effective November 5. George Cardoza has been appointed as the company’s new CFO. In the newly created role of company president, Ross Muken will oversee Sophia Genetics’ global business operations and work even more closely on strategic planning with CEO, Jurgi Camblong. He will continue to lead the company’s go-to-market function, including Clinical sales, BioPharma Dx sales, sales support, marketing, customer experience, and operations. Ross joined Sophia Genetics in February 2021 as CFO and was appointed as CFO and COO in March 2023. As CFO, Cardoza will oversee all corporate finance functions, including accounting, financial planning and analysis, investor relations, internal audit, tax, and treasury. Cardoza brings more than 30 years of experience in the precision medicine and clinical diagnostics industry, with extensive experience in both financial and operational leadership.